PURPOSE: To assess the efficacy and long-term results of Ethibloc treatment in @entity80 ( @entity80 ). METHODS: Thirteen @entity1 with @entity80 were treated with direct percutaneous Ethibloc injection. Four @entity1 had only one injection and the other nine @entity1 from two to four injections. No severe complications were observed; in two @entity1 a local leakage of Ethibloc from the cyst into the soft tissues occurred but it was temporary and the consequent inflammation self-healed without residua and sequelae. Imaging follow-up lasted from 6 to 67 months and included conventional radiology (CR) and magnetic resonance imaging (MRI), both used in the presurgical phase. RESULTS AND CONCLUSIONS: All images demonstrated a remarkable shrinkage of the @entity5409 and bone cortex thickening. In all @entity1 , circumscribed areas of lucency persisted at radiography, corresponding to residual cystic areas without fluid-fluid levels at MRI. @entity158 , which was present in all the @entity1 before treatment, was relieved within a month. According to our experience, direct percutaneous Ethibloc injection is effective in the treatment of @entity80 and can be recommended as the first-choice treatment. Due to its higher sensitivity MRI must be included either in the pretreatment phase to study the multilocular structure or in the imaging follow-up to evaluate the efficacy of Ethibloc in persistently non-responsive areas.

XXXX : treatment with direct percutaneous Ethibloc injection: long-term results.

@entity1 :: ('9606', 'Species') :: ['patients'] @entity80 :: ('MESH:D017824', 'Disease') :: ['ABC', 'aneurysmal bone cysts'] @entity5409 :: ('MESH:D052177', 'Disease') :: ['cystic lesion'] @entity158 :: ('MESH:D010146', 'Disease') :: ['Pain']
@entity80 :: (MESH:D017824,Disease) :: ['Aneurysmal bone cysts']
